Xgeva Sales Data
| Rank 91 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Xgeva U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 91 ( 1) |
$197,711 | 3.24% | 134 | 3.08% |
| Q3 2013 | 90 (4) |
$191,512 | 1.10% | 130 | 2.36% |
| Q2 2013 | 86 ( 8) |
$189,422 | 3.97% | 127 | 4.10% |
| Q1 2013 | 94 (2) |
$182,194 | 4.84% | 122 | 5.17% |
| Q4 2012 | 96 ( ) |
$173,788 | n/a | 116 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
